Recent news on Telmisartan

Independence very much a virtue at Boehringer Ingelheim  -  Mar 28, 2007
Pharma Times (subscription),Spiriva is one of three blockbusters that Boehringer boasts, the others being the blood pressure drug Micardis (telmisartan), sales of which rose 34% to 967

High-Normal Glucose Boosts Heart Failure Risk  -  Mar 7, 2007
MedPage Today,The cohort included 25620 patients enrolled in ONTARGET (Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial),

Even 'High Normal' Glucose Levels May Increase The Risk Of ...  -  Mar 7, 2007
Science Daily (press release)Held and colleagues performed an interim analysis on the blinded data from the ONgoing Telmisartan Alone and in combination with the Ramipril Global

Mitsubishi/Tanabe merger may be first of many in Japan  -  Feb 5, 2007
Pharma Times (subscription),...although Astellas reported strong sales of the blood pressure lowerer Micardis (telmisartan) and the immunosuppressant Prograf (tacrolimus).

Boehringer Ingelheim accesses field of oncology with three ...  09 Nov 2006
ONTARGET investigates multiple aspects of cardiovascular morbidity and mortality focusing on Micardis® (telmisartan), a once daily angiotensin II receptor ... -PipelineReview.com (press release), Largest-Ever Secondary Stroke Prevention Trial Completes ...  Oct 27, 2006
The study will also examine whether Boehringer Ingelheim's telmisartan (Micardis(R)), an angiotensin receptor blocker (ARB), in addition to the usual care in ... -Medical News Today (press release), Foro de Shell Security - Seguridad informática  Oct 26, 2006
Sup tegretol ression of hematopoiesis is likely mediated by an e telithromycin panded population of the following cytotoxic T lympho telmisartan ytes (CTLs ... -Shell Security, Research and Markets: Three of Boehringer Ingelheim's Current ...  Sep 5, 2006
...pulmonary disease. Micardis (telmisartan) is an angiotensin-II receptor blocker for the once-daily treatment of hypertension. Mobic ... -Genetic Engineering News

Glycemia levels prognostic in nondiabetics with heart failure: A ...  -  Nov 21, 2006
TheHeart.Org,...blinded interim analysis of patients initially free of HF enrolled in two ongoing "parallel" randomized trials, one (ONTARGET) comparing telmisartan,

Full Text  Aug 3, 2006
...and functional molecules (1–4). Its importance is reflected in the immense economic value of pharmaceuticals including Valsartan (5, 6) and Telmisartan (7, 8 ... -Science Magazine (subscription)

Nippon Boehringer Seeks Approval For Combo Hypertension Drug  Jun 28, 2006
...preparing similar ones. Nippon Boehringer has submitted for approval a drug that combines Micardis, or telmisartan, and the ... -Therapeutics Daily (subscription)



Diabetes And Kidney  May 9, 2006
...inhibitors (ACE inhibitors such as enalapril, ramipril, lisinopril, etc.) or angiotensin receptor blockers (ARBS such as losartan, irbesartan, telmisartan, etc ... - Newindpress (subscription)



Stock Watch  Jan 24, 2006
The product development and manufacturing pact involves development and supply of Boehringer’s hypertension drug, Telmisartan. ... - Express Pharma Pulse

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional